Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2015

View Archived Issues

Debio-1143 combination with carboplatin and paclitaxel feasible and active in solid tumor patients

Istituto Europeo di Oncologia describes KDM1A inhibitors

EMA supports E.U. orphan drug designation for Aduro Biotech's CRS-207 and GVAX pancreas

Committee backs E.U. orphan drug designation for axalimogene filolisbac in anal cancer

Compugen updates on development of immune checkpoint programs CGEN-15001T and CGEN-15022

Retrospective analysis reveals that L-DOPA is protective against AMD

University of Sydney and University of Technology, Sydney introduce omega-3 apoptosis inducers

American University, Washington and U.S. HHS report LCAT modulators

Clinical trial applications planned for CCT-245737

GliaCure completes proof-of-concept study of GC-021109 in Alzheimer's disease

TGA gives clearance for phase I/IIa trial of ISC-hPNSC in Parkinson's disease

X4 Pharmaceuticals reveals plans for development of CXCR4 receptor antagonist pipeline

Amgen reacquires rights to three launched products from GSK

Inception IBD completes financing and forms IBD therapeutics collaboration with Celgene

NDA submitted for KemPharm's KP-201/APAP, company requests priority review

CytoDyn receives FDA clearance for its first non-HIV indication for PRO-140

Pacira Pharmaceuticals comes to resolution with FDA regarding Exparel

RuiYi changes name to Bird Rock Bio

CardioPharma plans pharmacodynamic trial of triple combination CP-101

NUC-3373 shows potential to replace 5-FU as standard of care for colorectal cancer

New preclinical results presented for a novel recombinant factor VIII

Asana BioSciences presents unique B-raf inhibitor clinical candidate

Takeda to sell its respiratory disease portfolio to AstraZeneca

Arginase-1/2 inhibitor causes immune-mediated antitumor response in preclinical models

Eisai presents pharmacological profile of EP4 receptor antagonist E-7046

Dong-A presents Mer tyrosine kinase inhibitors

Esteve patents dual sigma1/mu-opioid receptor ligands

Julius-Maximilians-Universität Würzburg discloses HSP70 inhibitors

Foundation for Neglected Disease Research announces InhA inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...